ARIC Publications
Filters: Keyword is Enzyme-Linked Immunosorbent Assay [Clear All Filters]
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2015;30(1):77-83.
"Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(5):e001082.
"Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study." PLoS One. 2015;10(6):e0128452.
"Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study." Blood. 2010;116(23):5032-6.
"High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study." J Clin Endocrinol Metab. 2010;95(11):5097-104.
"Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels." Hum Mol Genet. 2010;19(9):1863-72.
"Leptin and incident type 2 diabetes: risk or protection?" Diabetologia. 2006;49(9):2086-96.
" "Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study." Eur Heart J. 2011;32(4):459-68.
"Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study." Arch Intern Med. 2003;163(10):1172-9.
"